• search
Non-GMP Pilot Development Facility Non-GMP Pilot Development Facility

Non-GMP Pilot Development Facility

Technology transfer from lab to market using the miniature version of glass cylindrical reactors.

Enabling pre-clinical program of NEW Chemical Entities (NCEs) and providing one stop solution to customize the product in rapid phase. The activities recorded in the electronic lab notebook enforces online documentation in accordance to principles of ALCOA+. Our value proposition: Discovery Research Quick access to the building blocks and key intermediates Time is essence of synthesis Enable the supply for discovery research 100g to few kilos 
Early phase development Quick access to Drug substance for toxicology studies Phase appropriate PRD to enable the scale up Non GMP facility: Flexible operation and accelerated delivery

Speak to our experts


  • 300+ fume hoods
  • Kilo lab with cylindrical reactor varying 5L to 50L capacity
  • Reactors from 500 L to 5000 L in Hyderabad & Bangalore
  • 50L autoclave a with 20kg/Cm2 design pressure
  • Pressure Nutsche filter, vaccum tray dryer and 20L rotavapor for downstream process
  • Huber unit to operate the process -20 to 150 degree Celsius
  • Internal network of strategic business partners
  • We also have a potent kilo lab

Scientific Expertise

  • Qualified PhDs and Postdocs in organic chemistry
  • 150+ scientists in chemistry and analytical services
  • 10+ process engineers and process safety engineers

Chemistry Capabilities

Expertise in

  • Metal promoted cross coupling reaction
  • Halogenation reactions
  • High pressure hydrogenation
  • Metal hydrate reactions
  • Carbohydrates
  • Lipids
  • Peptides
  • PEGylation
  • Asymmetric synthesis
  • Deuterated compound
  • Heterocyclic chemistry
  • Asymmetric hydrogenation
  • Chiral synthesis

Analytical Capability

  • High-performance liquid chromatography with varying detectors
  • Gas chromatography
  • Mass triple quad, 1H NMR Bruker
  • Differential scanning calorimeter
  • Micro calorimeter
  • Reaction calorimetry

Why Aurigene Pharmaceutical Services?

Quick turnaround of sample delivery

A strong scientific and analytical team

Infrastructure for mg to kg synthesis

Large network of qualified strategic business partners

Virtual Tour

Neoantigen Specific T cells For Cancer Immunotherapy

Neoantigen Specific T cells For Cancer Immunotherapy

An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence bypass central thymic tolerance. The success of immune checkpoint blockade...

Read More

Peptide Development and Manufacturing

Peptides are short chains of amino acids that are linked by peptide bonds. Several peptides linked together are called polypeptides. A protein contains one or more polypeptides. Therefore, proteins are long chains of amino acids held together by peptide bonds....

Read More

Biologics Process Scale-up Services

Built on a solid platform of development and manufacturing scientist, we enable scale up doe both upstream and downstream processes. ...

Read More

Expediting early development through innovative precision capsule filling technology

Introduction: Any new chemical entity (NCE) needs to undergo various stages of development such as preclinical and clinical trials before drug product is approved by regulatory agencies and available for patient. Formulations developed during early phases are simple formulations to enable phase appropriate studies like screening, dose ranging, toxicological and d...

Read More

Revisiting the reaction of b-chloroacroleins with 2-aminophenol: a new observation


The reaction of b-chloroacrolein with 1 equiv of 2-aminophenol in DMF proceeds smoothly to afford 11-hydroxy derivative of chromenoquinoline in good yield. This single pot method allows for a rapid access to a variety of chromenoquinolines or oxepinoquinolines depending on the nature of b-chloroacrolein used. The structures were established by spectroscopic data ...

Read More
View All

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.